EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency

Andrew Ross, Rebecca J Shaw, Louise Garth, Cathy Farrelly

Hematology Reports · 21.02.2025 · 17 (2) · 10

DOI: 10.3390/hematolrep17020010 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hematology Reports, online erschienen am 21.02.2025. Verfasst von Andrew Ross und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool University Hospital NHS Foundation Trust, Liverpool L7 8XP, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acquired factor X (FX) deficiency is a rare condition that can cause life threatening bleeding. Here we outline a successful management strategy for gastrointestinal bleeding (GI) using human FX concentrate. Case description: A 61-year-old male presented with upper GI bleeding and a prolonged prothrombin time. Investigations demonstrated an acquired FX deficiency (determined to be secondary to AL amyloidosis).

Results

Treatment with FX concentrate to maintain trough FX levels >20% resulted in successful cessation of bleeding symptoms, and levels >50% facilitated urgent invasive procedures.

Conclusions

This case report adds valuable insight into the management of this rare condition, and how best to utilize FX concentrates in acquired FX deficiency.

Schlagwörter

Stichwörter der Autor:innen

Coagadexamyloidosisfactor X

Autor:innen und Institutionen

  • Liverpool University Hospital NHS Foundation Trust, Liverpool L7 8XP, UK.
  • Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, Leahurst Campus, University of Liverpool, Liverpool CH64 7TEK, UK.

Zitieren

APA

Ross, A., Shaw, R. J., Garth, L., & Farrelly, C. (2025). Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency. Hematology Reports, 17(2), 10. https://doi.org/10.3390/hematolrep17020010

Vancouver

Ross A, Shaw RJ, Garth L, Farrelly C. Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency. Hematology Reports. 2025;17(2):10. doi:10.3390/hematolrep17020010

BibTeX
@article{Ross2025,
  author = {Ross, Andrew and Shaw, Rebecca J and Garth, Louise and Farrelly, Cathy},
  title = {Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency},
  journal = {Hematology Reports},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {10},
  doi = {10.3390/hematolrep17020010}
}
Kostenlos starten →